These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 2192878)

  • 21. [Specific features of lipid atherogenic modification in patients with ischemic heart disease and diabetes mellitus].
    Syrkin AL; Azizova OA; Drinitsina SV; Solovi'eva NP; Frenkel' EE; Savchenkova AP; Kliuchnikova TI
    Klin Med (Mosk); 2001; 79(4):25-9. PubMed ID: 11496733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Premature atherosclerosis in a 17-year-old male with diabetes mellitus and familial dyslipoproteinemia].
    Diaz Moncada SF; Quintanilla J; Lerman I; García Rubí E; Verdejo J; Posadas C
    Arch Inst Cardiol Mex; 1992; 62(3):257-62. PubMed ID: 1632717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The metabolic syndrome and hyper-Lp(a)-lipoproteinemia in peripheral obliterative atherosclerosis: 2 case reports].
    Tesić D; Derić M; Ivković-Lazar T; Pantelinac P; Lepsanović L
    Med Pregl; 1996; 49(7-8):313-7. PubMed ID: 8926951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.
    Mackness B; McElduff P; Mackness MI
    J Intern Med; 2005 Oct; 258(4):363-8. PubMed ID: 16164576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and management of lipid disorders in diabetes. American Diabetes Association.
    Diabetes Care; 1993 May; 16(5):828-34. PubMed ID: 8495626
    [No Abstract]   [Full Text] [Related]  

  • 26. Statins and diabetes.
    Carmena R; Betteridge DJ
    Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoproteinemia and diabetes mellitus].
    Růzek V
    Vnitr Lek; 1992 Jul; 38(7):715-20. PubMed ID: 1413578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hyperlipidemia during diabetes mellitus. Recent developments].
    Guerci B; Ziegler O; Drouin P
    Presse Med; 1994 Jan; 23(2):82-8. PubMed ID: 8140078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Atherosclerosis and juvenile dyslipidemias].
    Calvani M
    Recenti Prog Med; 1994 Mar; 85(3):204-11. PubMed ID: 8184205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiovascular diseases and clinical laboratory examination. (5). Atherosclerosis and abnormal metabolism of lipids].
    Hirabaru K; Yamasaki S
    Rinsho Byori; 1983 Oct; 31(10):1078-82. PubMed ID: 6674578
    [No Abstract]   [Full Text] [Related]  

  • 32. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
    Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
    Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic dyslipidemia.
    Chahil TJ; Ginsberg HN
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):491-510, vii-viii. PubMed ID: 16959582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pathophysiologic aspects of hyperlipoproteinemias].
    Soska V
    Vnitr Lek; 2000 Sep; 46(9):506-9. PubMed ID: 11344641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dyslipoproteinemias in diabetes.
    Steiner G
    Clin Invest Med; 1995 Aug; 18(4):282-7. PubMed ID: 8549014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atherogenic factors in diabetes: the role of lipoprotein metabolism.
    Crepaldi G; Manzato E
    Postgrad Med J; 1988; 64 Suppl 3():10-2. PubMed ID: 3074293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diabetes mellitus, HDL-cholesterol and vascular disease].
    Rubiés-Prat J; Masdeu S; Masana L; Nubiola AR
    Med Clin (Barc); 1982 Nov 1-15; 79(8):348-50. PubMed ID: 7176746
    [No Abstract]   [Full Text] [Related]  

  • 38. Influence of various therapies on hyperlipidemia in diabetes mellitus.
    Calvert GD; Jenkins A; Abbey M
    Horm Metab Res Suppl; 1985; 15():94-8. PubMed ID: 3865889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A; Heurtier A
    Diabetes Metab; 1999 Jun; 25 Suppl 3():12-20. PubMed ID: 10421988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.